Journey Medical (DERM) Change in Accured Expenses (2020 - 2026)

Journey Medical has reported Change in Accured Expenses for 7 years, with the latest figure at -$8000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 65.22% year-over-year to -$8000.0; the trailing twelve-month figure through Mar 2026 stood at $9000.0 (down 98.67% YoY), and the FY2025 full-year result was -$6000.0, down 101.57% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$8000.0, up from -$3.8 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $5.3 million in Q4 2022, with the low at -$3.8 million in Q4 2025.
• Historically, Change in Accured Expenses has averaged $87647.1 across 5 years, with a median of -$8000.0 in 2026.
• Annual changes were most pronounced in 2024 — Change in Accured Expenses sank 6440.0% — and 2025, when it surged 845.05%.
• Journey Medical's Change in Accured Expenses stood at $5.3 million in 2022, then declined by 18.92% to $4.3 million in 2023, then slumped by 98.33% to $72000.0 in 2024, then tumbled by 5351.39% to -$3.8 million in 2025, then soared by 99.79% to -$8000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$8000.0 (Q1 2026), -$3.8 million (Q4 2025), and -$1.4 million (Q3 2025), per Business Quant data.